Start up costs and suspension deepen losses at Clinicenta

The suspension of a major contract has pushed losses deeper at independent sector treatment centre (ISTC) provider Clinicenta.Turnover at the Carillion-owned company increased almost three-fold in the year ended 31 December 2009 following commencement of its five-year North London ISTC contract in April 2009. However, by November the out-of-hospital services component of the contract had…

Membership Required

You must be a HM Subscriber to view this content.

Subscribe Now »

Already have an account?